In this 6-month randomized, multicenter trial, patients with type 1 diabetes were assigned in a 2:1 ratio to receive treatment with a closed-loop system (closed-loop group) or a sensor-augmented pump (control group).
what dose of diflucan for yeast infection 9 months in the nivolumab group, as compared with 19.